PedAM
Pediatric Disease Annotations & Medicines
| Disease | cerebral palsy |
| Symptom | |spasticity |
| Sentences | 58 |
| PubMedID- 21087238 | Interpretation: the outcomes of neuronox, based on prs, proved to be as effective and safe as those of botox for the treatment of spasticity in individuals with cerebral palsy. |
| PubMedID- 23039838 | Object: intrathecal baclofen therapy has been used successfully for intractable spasticity in children with cerebral palsy. |
| PubMedID- 20430330 | The use of botulinum toxins to decrease spasticity in children with cerebral palsy has become standard of care during the past decade. |
| PubMedID- 23885344 | Tendon structure and extracellular matrix components are affected by spasticity in cerebral palsy patients. |
| PubMedID- 22506201 | Dystonia, a symptom involving involuntary and irregular contraction of muscles, causes movement disorders and postural problems and is often found in cerebral palsy (cp) mixed with spasticity.1 dystonia in cp is mainly caused by damage to the extrapyramidal system such as thalamus and basal ganglia, which can occur by hypoxic brain damage or kernicterus.2 it is also common for these patients to have later changes in the musculoskeletal system due to spasticity, dyskinesia, and dystonia. |
| PubMedID- 25613095 | Treatment of spasticity in children with cerebral palsy with botulinum toxin a. |
| PubMedID- 25755853 | The management of spasticity in children with cerebral palsy requires a multidisciplinary effort and should be started as early as possible. |
| PubMedID- 20831013 | Background: spasticity in patients with infantile cerebral palsy may lead to progressive subluxation and/or hip dislocation. |
| PubMedID- 22659636 | Intraobserver reliability of modified ashworth scale and modified tardieu scale in the assessment of spasticity in children with cerebral palsy. |
| PubMedID- 22207070 | Aim: the aim of this study was to evaluate the efficacy and safety of radial extracorporeal shock wave therapy (reswt) in the treatment of spasticity in patients with cerebral palsy. |
| PubMedID- 24348041 | In this context, results of this study suggest that specific cerebellar stimulation may influence highly decreased information transference measured by pti between left and right autonomic neural activities, reflecting brain left and right ipsilateral modulatory influences, and may specifically influence spastic symptoms in cerebral palsy, leading to decreased spasticity and relaxed state. |
| PubMedID- 21540003 | The purpose of this article is to provide an overview of available medications for treatment of spasticity in children with cerebral palsy. |
| PubMedID- 20633177 | Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement. |
| PubMedID- 22641937 | According to the recommendations of the french health products safety agency (afssaps) in 2009, botulinum toxin injections are recommended to reduce spasticity in children with cerebral palsy. |
| PubMedID- 26046690 | A 15-year-old boy underwent an uncomplicated placement of an intrathecal baclofen pump for the treatment of spasticity due to cerebral palsy. |
| PubMedID- 21800690 | Selective dorsal rhizotomy (sdr) is a surgical technique for reducing spasticity associated with cerebral palsy (cp). |
| PubMedID- 21624819 | Classification of topographical pattern of spasticity in cerebral palsy: a registry perspective. |
| PubMedID- 20139400 | Baclofen is widely used to control spasticity in children with cerebral palsy. |
| PubMedID- 20655641 | The aim of this study is to examine the relationship between gait efficiency, gait kinematics, lower limb muscle strength, and muscular spasticity in adolescents with cerebral palsy. |
| PubMedID- 25846806 | Reliability and validity of the duncan-ely test for assessing rectus femoris spasticity in patients with cerebral palsy. |
| PubMedID- 20602795 | Use of bont-a for the treatment of upper limb spasticity in children with cerebral palsy has become routine clinical practice in many paediatric treatment centres worldwide. |
| PubMedID- 22069422 | All the patients having upper limb spasticity due to cerebral palsy were evaluated for muscle spasticity and control by using modified ashworth's scale and selective voluntary control grading tables 1 and 2 respectively. |
| PubMedID- 20298838 | Relationship between age and spasticity in children with diplegic cerebral palsy. |
| PubMedID- 22041808 | Preliminary evidence of focal muscle vibration effects on spasticity due to cerebral palsy in a small sample of italian children. |
| PubMedID- 23967895 | To manage spasticity in children with spastic cerebral palsy botulinum toxin type-a (btx-a) injected by manual intramuscular needle placement in the lower extremity under general anaesthesia is an established treatment and standard of care in children with spastic cp . |
| PubMedID- 26077594 | Purpose: selective dorsal rhizotomy (sdr) is a neurosurgical procedure used to treat spasticity in children with cerebral palsy (cp). |
| PubMedID- 22851256 | Updates in the treatment of spasticity associated with cerebral palsy. |
| PubMedID- 26576411 | A stiff-knee gait pattern is frequently associated with several impairments including quadriceps spasticity in children diagnosed with cerebral palsy (cp). |
| PubMedID- 25803254 | Objective: the aim of this study was to determine the efficacy of semitendinosus and gastrocnemius tenotomies on popliteal angle presenting knee flexion spasticity in children with cerebral palsy (cp). |
| PubMedID- 25200577 | Functional posterior rhizotomy, mostly used to treat paraplegic spasticity in children with cerebral palsy, involves the sectioning of posterior rootlets associated with abnormal motor responses to electrical stimulation. |
| PubMedID- 25084089 | Intrathecal baclofen (itb) is a reversible treatment that reduces muscle tone to ameliorate spasticity and dystonia in patients with cerebral palsy (cp). |
| PubMedID- 23428186 | Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum a toxin. |
| PubMedID- 25536713 | Reduction of spasticity in cerebral palsy by anodal transcranial direct current stimulation. |
| PubMedID- 20223745 | Evaluation of spasticity in children with cerebral palsy using ashworth and tardieu scales compared with laboratory measures. |
| PubMedID- 20613938 | Multilevel botulinum toxin type a as a treatment for spasticity in children with cerebral palsy: a retrospective study. |
| PubMedID- 21772975 | Human studies have reported potential benefits in bone , muscle function , balance and prevention of falls , reduction of muscle spasticity in those with cerebral palsy , and postural control in those with parkinson's disease . |
| PubMedID- 24432099 | Objectives: in the last 2 decades, btx-a is increasingly being used in the management of spasticity in children with cerebral palsy (cp) and there is no doubt about its effect on range of motion, spasticity reduction and gait pattern in this patient population. |
| PubMedID- 20493744 | In the last few years botulinum toxin type a (btx-a) has been widely used in the management of spasticity in children with cerebral palsy in order to reduce hypertonicity and improve functional outcomes enhancing motor skill development. |
| PubMedID- 20298834 | Reliability of the tardieu scale for assessing spasticity in children with cerebral palsy. |
| PubMedID- 23044016 | Peripheral magnetic stimulation to decrease spasticity in cerebral palsy. |
| PubMedID- 22835588 | Methods: eighty-six patients (90 elbows) were treated for elbow spasticity due to cerebral palsy. |
| PubMedID- 22069575 | As well as involuntary movement disorders, bont has been used to treat muscle tone disorders, including spasticity associated with cerebral palsy, stroke, brain trauma and multiple sclerosis . |
| PubMedID- 26167363 | in a study of 43 patients with severe spasticity due to cerebral palsy, 19 patients developed spinal distortions including scoliosis, lumbar hyperlordosis, thoracic hyperkyphosis, and l4–l5 spondylolisthesis postsurgically. |
| PubMedID- 21102209 | Background: crouch gait in cerebral palsy is associated with spasticity and contracture of the hamstrings and weakness of the extensors of the hip and knee and ankle plantar flexors. |
| PubMedID- 23346608 Management of Spasticity and Co-Existing Motor Disorders and Their Early Musculoskeletal Complications | The guideline covers the management of spasticity associated with cerebral palsy, but not all aspects of the management of cerebral palsy. |
| PubMedID- 23175906 | Conclusion: personal care and mobility which are aspects of the health related quality of life should be paid more attention to, as they are negatively affected by spasticity in patients with cerebral palsy. |
| PubMedID- 20101040 | Objective: to evaluate published evidence of efficacy and safety of pharmacologic treatments for childhood spasticity due to cerebral palsy. |
| PubMedID- 23218728 | A clinical measurement to quantify spasticity in children with cerebral palsy by integration of multidimensional signals. |
| PubMedID- 20121371 | Object: intrathecal baclofen is an effective treatment for spasticity in patients with cerebral palsy. |
| PubMedID- 24175866 | Selective dorsal rhizotomy for spasticity not associated with cerebral palsy: reconsideration of surgical inclusion criteria. |
Page: 1 2